We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug Candidate

News   Jan 16, 2018 | Original story from Wyss Institute

 
Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug Candidate

The blood-vessel-on-a-chip consists of parallel channels (red) lined with human endothelial cells, through which whole blood and other compounds can be perfused, to mimic the function of blood vessels in the human body. Credit: Wyss Institute at Harvard University

 
 
Advertisement
 

RELATED ARTICLES

Oxford's COVID-19 Vaccine Has 70% Efficacy Rate

News

There are now over 170 teams of researchers working to develop a vaccine for protection against COVID-19. Over the last few weeks, a number of groups shared interim analysis data on candidates that have reached Phase III clinical testing. The latest addition is the University of Oxford – in collaboration with the pharmaceutical company AstraZeneca – who today announce an efficacy of 70.4% for the candidate, ChAdOx1 nCoV-2019.

READ MORE

Metal-Organic Frameworks Successfully Deliver CRISPR/Cas9 Into Human Cancer Cells

News

Researchers used metal-organic frameworks (MOFs) enhanced with a green tea phytochemical coating to target human prostate cancer cells for the first time.

READ MORE

Folding of SARS-CoV2 Genome Reveals Drug Targets

News

Research alliance has observed the RNA folding structures of the SARS-CoV2 genome with which the virus controls the infection process.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE